Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

Prostaglandins

Volumn 13, Issue 3, 1977, Pages 389-397

  Tateson, J E ^a   Moncada, S ^a   Vane, J R ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ADENYLATE CYCLASE; ARACHIDONIC ACID; CYCLIC AMP; ENZYME; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN H2;

DOSE RESPONSE; DRUG COMPARISON; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IN VITRO STUDY; NORMAL HUMAN; THEORETICAL STUDY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ARACHIDONIC ACIDS; BLOOD PLATELETS; COMPARATIVE STUDY; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; PLATELET AGGREGATION; PROSTAGLANDINS E; PROSTAGLANDINS F;

EID: 0017350520     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-6980(77)90019-3     Document Type: Article

References (30)

1. Drugs that affect platelet behaviour
2. Prostaglandins and platelet function
3. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
4. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
5. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
6. Human arterial and venous tissue generates prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation
7. The chemical characterization of prostaglandin X (prostacyclin)
8. Arterial walls generate from prostaglandin endoperoxides a substance which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
9. Prostacyclin (PGX) is the endogenous metabolite of arachidonic acid which relaxes coronary arteries
10. Prostaglandins, cyclic AMP, and platelet function
11. 2
12. A protein binding assay for cAMP
13. The influence on platelet aggregation of drugs that affect the accumulation of cAMP in platelets
14. Platelet phosphodiesterase and its inhibition by vasodilators
15. β-Adrenergic receptors in human platelets
16. Platelet aggregation III
17. Cyclic AMP in human blood platelets
18. Interaction of chick skin fragment with human platelets
19. An endoperoxide aggregator (LASS) formed in platelets in response to thrombotic stimuli
20. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation
21. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
22. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid
23. 2) in human platelets
24. 1 on the level of cAMP in human blood platelets
25. 1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including cAMP
26. 1 on the adenyl cyclase system of human and rabbit blood platelets
27. 1
28. The control of platelet responsiveness by agents that influence cyclic AMP metabolism
29. 2